The results of T-lymphocyte proliferation experiments showed that the ability of PMN-MDSCs to inhibit CD8 T-lymphocyte proliferation is stronger than that of M-MDSCs in B16-F10 tumour-bearing mice (Fig. 1c–d). The gene discussed is CD8A; the disease is neoplasm.